Detail Information of Exogenous Modulation

General Information of Drug Transporter (DT)
DT ID	DTD0024 Transporter Info
Gene Name	SLC22A6
Transporter Name	Organic anion transporter 1
Gene ID	9356
UniProt ID	Q4U2R8

Exogenous factors (drugs, dietary constituents, etc.) Modulation of This DT (EGM)
Approved Drug
Probenecid	12 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation 1	Probenecid inhibits the transportation of 6-Carboxyfluorescein by SLC22A6 (IC50 = 6.3 microM)			[1]
Affected Drug/Substrate	6-Carboxyfluorescein	Modulation Type	Inhibition
Cell System	Chinese hamster ovary (CHO) cells-OAT1
DT Modulation 2	Probenecid inhibits the transportation of Adefovir by SLC22A6 (IC50 = 7.4 microM)			[2]
Affected Drug/Substrate	Adefovir	Modulation Type	Inhibition
Cell System	Chinese hamster ovary (CHO) cells-OAT1
DT Modulation 3	Probenecid inhibits the transportation of Aminohippuric acid by SLC22A6 (IC50 = 6.5 microM)			[3]
Affected Drug/Substrate	Aminohippuric acid	Modulation Type	Inhibition
Cell System	Chinese hamster ovary (CHO) cells-OAT1
DT Modulation 4	Probenecid inhibits the transportation of Aminohippuric acid by SLC22A6 (Ki = 12.1 microM)			[4]
Affected Drug/Substrate	Aminohippuric acid	Modulation Type	Inhibition
Cell System	The Proximal Tubule (S2) Cells-OAT1
DT Modulation 5	Probenecid inhibits the transportation of Aminohippuric acid by SLC22A6 (IC50 = 17 microM)			[5]
Affected Drug/Substrate	Aminohippuric acid	Modulation Type	Inhibition
Cell System	Oocytes-OAT1
DT Modulation 6	Probenecid inhibits the transportation of Cidofovir by SLC22A6 (IC50 = 3.9 microM)			[6]
Affected Drug/Substrate	Cidofovir	Modulation Type	Inhibition
Cell System	Chinese hamster ovary (CHO) cells-OAT1
DT Modulation 7	Probenecid inhibits the transportation of Dimesna by SLC22A6 (Ki = 26 microM)			[7]
Affected Drug/Substrate	Dimesna	Modulation Type	Inhibition
Cell System	Human cervical cancer cell line (Hela)-OAT1
DT Modulation 8	Probenecid inhibits the transportation of Methotrexate by SLC22A6 (IC50 = 17 microM)			[5]
Affected Drug/Substrate	Methotrexate	Modulation Type	Inhibition
Cell System	Oocytes-OAT1
DT Modulation 9	Probenecid inhibits the transportation of Ochratoxin A by SLC22A6 (Ki = 4.29 microM)			[8]
Affected Drug/Substrate	Ochratoxin A	Modulation Type	Inhibition
Cell System	The Proximal Tubule (S2) Cells-OAT1
DT Modulation 10	Probenecid inhibits the transportation of Aminohippuric acid by SLC22A6			[9]
Affected Drug/Substrate	Aminohippuric acid	Modulation Type	Inhibition
Cell System	Human embryonic kidney 293 cells (HEK293)-OAT1
DT Modulation 11	Probenecid inhibits the activity of SLC22A6			[10] , [11]
DT Modulation 12	Probenecid inhibits the activity of SLC22A6			[25]
Betamipron	4 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation 1	Betamipron inhibits the transportation of Adefovir by SLC22A6 (IC50 = 6 microM)			[2]
Affected Drug/Substrate	Adefovir	Modulation Type	Inhibition
Cell System	Chinese hamster ovary (CHO) cells-OAT1
DT Modulation 2	Betamipron inhibits the transportation of Aminohippuric acid by SLC22A6 (IC50 = 16.2 microM)			[3]
Affected Drug/Substrate	Aminohippuric acid	Modulation Type	Inhibition
Cell System	Chinese hamster ovary (CHO) cells-OAT1
DT Modulation 3	Betamipron inhibits the transportation of Aminohippuric acid by SLC22A6 (Ki = 23.6 microM)			[4]
Affected Drug/Substrate	Aminohippuric acid	Modulation Type	Inhibition
Cell System	The Proximal Tubule (S2) Cells-OAT1
DT Modulation 4	Betamipron inhibits the activity of SLC22A6			[14]
Cell System	The Proximal Tubule (S2) Cells-OAT1
Piroxicam	4 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation 1	Piroxicam inhibits the transportation of Adefovir by SLC22A6 (IC50 = 20.5 microM)			[2]
Affected Drug/Substrate	Adefovir	Modulation Type	Inhibition
Cell System	Chinese hamster ovary (CHO) cells-OAT1
DT Modulation 2	Piroxicam inhibits the transportation of Aminohippuric acid by SLC22A6 (IC50 = 62.8 microM)			[15]
Affected Drug/Substrate	Aminohippuric acid	Modulation Type	Inhibition
Cell System	The Proximal Tubule (S2) Cells-OAT1
DT Modulation 3	Piroxicam inhibits the transportation of Ochratoxin A by SLC22A6 (Ki = 19.8 microM)			[8]
Affected Drug/Substrate	Ochratoxin A	Modulation Type	Inhibition
Cell System	The Proximal Tubule (S2) Cells-OAT1
DT Modulation 4	Piroxicam inhibits the activity of SLC22A6			[8]
Ketoprofen	3 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation 1	Ketoprofen inhibits the transportation of 6-Carboxyfluorescein by SLC22A6 (IC50 = 1.4 microM)			[1]
Affected Drug/Substrate	6-Carboxyfluorescein	Modulation Type	Inhibition
Cell System	Chinese hamster ovary (CHO) cells-OAT1
DT Modulation 2	Ketoprofen inhibits the transportation of Adefovir by SLC22A6 (IC50 = 1.3 microM)			[2]
Affected Drug/Substrate	Adefovir	Modulation Type	Inhibition
Cell System	Chinese hamster ovary (CHO) cells-OAT1
DT Modulation 3	Ketoprofen inhibits the transportation of Aminohippuric acid by SLC22A6 (IC50 = 4.34 microM)			[15]
Affected Drug/Substrate	Aminohippuric acid	Modulation Type	Inhibition
Cell System	The Proximal Tubule (S2) Cells-OAT1
Indomethacin	3 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation 1	Indomethacin inhibits the transportation of Adefovir by SLC22A6 (IC50 = 3 microM)			[2]
Affected Drug/Substrate	Adefovir	Modulation Type	Inhibition
Cell System	Chinese hamster ovary (CHO) cells-OAT1
DT Modulation 2	Indomethacin inhibits the transportation of Aminohippuric acid by SLC22A6 (IC50 = 3.83 microM)			[15]
Affected Drug/Substrate	Aminohippuric acid	Modulation Type	Inhibition
Cell System	The Proximal Tubule (S2) Cells-OAT1
DT Modulation 3	Indomethacin inhibits the activity of SLC22A6			[18]
Simvastatin	3 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation 1	Simvastatin inhibits the transportation of Aminohippuric acid by SLC22A6 (IC50 = 41.5 microM)			[16]
Affected Drug/Substrate	Aminohippuric acid	Modulation Type	Inhibition
Cell System	Oocytes-OAT1
DT Modulation 2	Simvastatin inhibits the transportation of Aminohippuric acid by SLC22A6 (IC50 = 73.6 microM)			[17]
Affected Drug/Substrate	Aminohippuric acid	Modulation Type	Inhibition
Cell System	The Proximal Tubule (S2) Cells-OAT1
DT Modulation 3	Simvastatin inhibits the activity of SLC22A6			[16]
Adefovir	3 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation 1	Adefovir inhibits the transportation of Ibuprofen by SLC22A6 (IC50 = 1.5 microM)			[2]
Affected Drug/Substrate	Ibuprofen	Modulation Type	Inhibition
Cell System	Chinese hamster ovary (CHO) cells-OAT1
DT Modulation 2	Adefovir inhibits the transportation of Ketoprofen by SLC22A6 (IC50 = 0.9 microM)			[2]
Affected Drug/Substrate	Ketoprofen	Modulation Type	Inhibition
Cell System	Chinese hamster ovary (CHO) cells-OAT1
DT Modulation 3	Adefovir inhibits the transportation of Naproxen by SLC22A6 (IC50 = 1.8 microM)			[2]
Affected Drug/Substrate	Naproxen	Modulation Type	Inhibition
Cell System	Chinese hamster ovary (CHO) cells-OAT1
Salicylic Acid	2 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation 1	Salicylic acid inhibits the transportation of 6-Carboxyfluorescein by SLC22A6 (IC50 = 280 microM)			[1]
Affected Drug/Substrate	6-Carboxyfluorescein	Modulation Type	Inhibition
Cell System	Chinese hamster ovary (CHO) cells-OAT1
DT Modulation 2	Salicylic acid inhibits the transportation of Aminohippuric acid by SLC22A6 (IC50 = 325 microM)			[15]
Affected Drug/Substrate	Aminohippuric acid	Modulation Type	Inhibition
Cell System	The Proximal Tubule (S2) Cells-OAT1
Diclofenac	2 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation 1	Diclofenac inhibits the transportation of Adefovir by SLC22A6 (IC50 = 4 microM)			[2]
Affected Drug/Substrate	Adefovir	Modulation Type	Inhibition
Cell System	Chinese hamster ovary (CHO) cells-OAT1
DT Modulation 2	Diclofenac inhibits the transportation of Aminohippuric acid by SLC22A6 (IC50 = 4.46 microM)			[15]
Affected Drug/Substrate	Aminohippuric acid	Modulation Type	Inhibition
Cell System	The Proximal Tubule (S2) Cells-OAT1
Ibuprofen	2 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation 1	Ibuprofen inhibits the transportation of Adefovir by SLC22A6 (IC50 = 8 microM)			[2]
Affected Drug/Substrate	Adefovir	Modulation Type	Inhibition
Cell System	Chinese hamster ovary (CHO) cells-OAT1
DT Modulation 2	Ibuprofen inhibits the transportation of Aminohippuric acid by SLC22A6 (IC50 = 55.6 microM)			[15]
Affected Drug/Substrate	Aminohippuric acid	Modulation Type	Inhibition
Cell System	The Proximal Tubule (S2) Cells-OAT1
Naproxen	2 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation 1	Naproxen inhibits the transportation of Adefovir by SLC22A6 (IC50 = 5.8 microM)			[2]
Affected Drug/Substrate	Adefovir	Modulation Type	Inhibition
Cell System	Chinese hamster ovary (CHO) cells-OAT1
DT Modulation 2	Naproxen inhibits the transportation of Aminohippuric acid by SLC22A6 (IC50 = 5.67 microM)			[15]
Affected Drug/Substrate	Aminohippuric acid	Modulation Type	Inhibition
Cell System	The Proximal Tubule (S2) Cells-OAT1
Chlorothiazide	2 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation 1	Chlorothiazide inhibits the transportation of Aminohippuric acid by SLC22A6 (IC50 = 3.78 microM)			[19]
Affected Drug/Substrate	Aminohippuric acid	Modulation Type	Inhibition
Cell System	The Proximal Tubule (S2) Cells-OAT1
DT Modulation 2	Chlorothiazide inhibits the activity of SLC22A6			[23]
Cyclothiazide	2 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation 1	Cyclothiazide inhibits the transportation of Aminohippuric acid by SLC22A6 (IC50 = 84.3 microM)			[19]
Affected Drug/Substrate	Aminohippuric acid	Modulation Type	Inhibition
Cell System	The Proximal Tubule (S2) Cells-OAT1
DT Modulation 2	Cyclothiazide inhibits the activity of SLC22A6			[23]
Furosemide	2 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation 1	Furosemide inhibits the transportation of Aminohippuric acid by SLC22A6 (IC50 = 18 microM)			[19]
Affected Drug/Substrate	Aminohippuric acid	Modulation Type	Inhibition
Cell System	The Proximal Tubule (S2) Cells-OAT1
DT Modulation 2	Furosemide inhibits the activity of SLC22A6			[18]
Hydrochlorothiazide	2 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation 1	Hydrochlorothiazide inhibits the transportation of Aminohippuric acid by SLC22A6 (IC50 = 67.3 microM)			[19]
Affected Drug/Substrate	Aminohippuric acid	Modulation Type	Inhibition
Cell System	The Proximal Tubule (S2) Cells-OAT1
DT Modulation 2	Hydrochlorothiazide inhibits the activity of SLC22A6 (Ki = 150 microM)			[23]
Rifampicin	2 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation 1	Rifampicin inhibits the transportation of Aminohippuric acid by SLC22A6 (IC50 = 79.1 microM)			[20]
Affected Drug/Substrate	Aminohippuric acid	Modulation Type	Inhibition
Cell System	Oocytes-OAT1
DT Modulation 2	Rifampicin inhibits the transportation of Olmesartan medoxomil by SLC22A6 (Ki = 62.2 microM)			[20]
Affected Drug/Substrate	Olmesartan medoxomil	Modulation Type	Inhibition
Cell System	Oocytes-OAT1
Cephradine	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation 1	Cephradine inhibits the transportation of 6-Carboxyfluorescein by SLC22A6 (IC50 = 1600 microM)			[1]
Affected Drug/Substrate	6-Carboxyfluorescein	Modulation Type	Inhibition
Cell System	Chinese hamster ovary (CHO) cells-OAT1
Cidofovir	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation 1	Cidofovir inhibits the transportation of 6-Carboxyfluorescein by SLC22A6 (IC50 = 60 microM)			[1]
Affected Drug/Substrate	6-Carboxyfluorescein	Modulation Type	Inhibition
Cell System	Chinese hamster ovary (CHO) cells-OAT1
Diflunisal	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation 1	Diflunisal inhibits the transportation of Adefovir by SLC22A6 (IC50 = 0.85 microM)			[2]
Affected Drug/Substrate	Adefovir	Modulation Type	Inhibition
Cell System	Chinese hamster ovary (CHO) cells-OAT1
Etodolac	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation 1	Etodolac inhibits the transportation of Adefovir by SLC22A6 (IC50 = 50 microM)			[2]
Affected Drug/Substrate	Adefovir	Modulation Type	Inhibition
Cell System	Chinese hamster ovary (CHO) cells-OAT1
Flurbiprofen	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation 1	Flurbiprofen inhibits the transportation of Adefovir by SLC22A6 (IC50 = 1.5 microM)			[2]
Affected Drug/Substrate	Adefovir	Modulation Type	Inhibition
Cell System	Chinese hamster ovary (CHO) cells-OAT1
Cilastatin	2 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation 1	Cilastatin inhibits the transportation of Aminohippuric acid by SLC22A6 (Ki = 1470 microM)			[4]
Affected Drug/Substrate	Aminohippuric acid	Modulation Type	Inhibition
Cell System	The Proximal Tubule (S2) Cells-OAT1
DT Modulation 2	Cilastatin inhibits the uptake of diclofenac acyl glucuronide by SLC22A6			[36]
Affected Drug/Substrate	Diclofenac acyl glucuronide	Modulation Type	Inhibition
Cell System	Human embryonic kidney 293 cells (HEK293)-OAT1
Acetazolamide	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation 1	Acetazolamide inhibits the transportation of Aminohippuric acid by SLC22A6 (IC50 = 75 microM)			[19]
Affected Drug/Substrate	Aminohippuric acid	Modulation Type	Inhibition
Cell System	The Proximal Tubule (S2) Cells-OAT1
Bumetanide	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation 1	Bumetanide inhibits the transportation of Aminohippuric acid by SLC22A6 (IC50 = 7.6 microM)			[19]
Affected Drug/Substrate	Aminohippuric acid	Modulation Type	Inhibition
Cell System	The Proximal Tubule (S2) Cells-OAT1
Ethacrynic Acid	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation 1	Ethacrynic acid inhibits the transportation of Aminohippuric acid by SLC22A6 (IC50 = 29.6 microM)			[19]
Affected Drug/Substrate	Aminohippuric acid	Modulation Type	Inhibition
Cell System	The Proximal Tubule (S2) Cells-OAT1
Methazolamide	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation 1	Methazolamide inhibits the transportation of Aminohippuric acid by SLC22A6 (IC50 = 438 microM)			[19]
Affected Drug/Substrate	Aminohippuric acid	Modulation Type	Inhibition
Cell System	The Proximal Tubule (S2) Cells-OAT1
Trichlormethiazide	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation 1	Trichloromethiazide inhibits the transportation of Aminohippuric acid by SLC22A6 (IC50 = 19.2 microM)			[19]
Affected Drug/Substrate	Aminohippuric acid	Modulation Type	Inhibition
Cell System	The Proximal Tubule (S2) Cells-OAT1
Novobiocin	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation 1	Novobiocin inhibits the transportation of Aminohippuric acid by SLC22A6 (IC50 = 34.8 microM; Ki = 14.9 microM)			[26]
Affected Drug/Substrate	Aminohippuric acid	Modulation Type	Inhibition
Cell System	Monkey kidney tissue Fibroblast-like cell lines (COS)7-OAT1
Aspirin	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation 1	Aspirin inhibits the transportation of Aminohippuric acid by SLC22A6 (IC50 = 769 microM)			[15]
Affected Drug/Substrate	Aminohippuric acid	Modulation Type	Inhibition
Cell System	The Proximal Tubule (S2) Cells-OAT1
Mefenamic Acid	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation 1	Mefenamic acid inhibits the transportation of Aminohippuric acid by SLC22A6 (IC50 = 0.83 microM)			[15]
Affected Drug/Substrate	Aminohippuric acid	Modulation Type	Inhibition
Cell System	The Proximal Tubule (S2) Cells-OAT1
Sulindac	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation 1	Sulindac inhibits the transportation of Aminohippuric acid by SLC22A6 (IC50 = 36.2 microM)			[15]
Affected Drug/Substrate	Aminohippuric acid	Modulation Type	Inhibition
Cell System	The Proximal Tubule (S2) Cells-OAT1
Fluvastatin	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation 1	Fluvastatin inhibits the transportation of Aminohippuric acid by SLC22A6 (IC50 = 26.3 microM)			[17]
Affected Drug/Substrate	Aminohippuric acid	Modulation Type	Inhibition
Cell System	The Proximal Tubule (S2) Cells-OAT1
Pravastatin	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation 1	Pravastatin inhibits the transportation of Aminohippuric acid by SLC22A6 (IC50 = 408 microM)			[17]
Affected Drug/Substrate	Aminohippuric acid	Modulation Type	Inhibition
Cell System	The Proximal Tubule (S2) Cells-OAT1
Ketoconazole	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation 1	Ketoconazole inhibits the transportation of Aminohippuric acid by SLC22A6 (IC50 = 319 microM)			[20]
Affected Drug/Substrate	Aminohippuric acid	Modulation Type	Inhibition
Cell System	Oocytes-OAT1
Sulfasalazine	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation 1	Sulfasalazine inhibits the transportation of Methotrexate by SLC22A6 (IC50 = 4.6 microM)			[5]
Affected Drug/Substrate	Methotrexate	Modulation Type	Inhibition
Cell System	Oocytes-OAT1
Cefadroxil	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation 1	Cefadroxil inhibits the transportation of Prostaglandin F2alpha by SLC22A6 (Ki = 6140 microM)			[22]
Affected Drug/Substrate	Prostaglandin F2alpha	Modulation Type	Inhibition
Cell System	The Proximal Tubule (S2) Cells-OAT1
Cefamandole	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation 1	Cefamandole inhibits the transportation of Prostaglandin F2alpha by SLC22A6 (Ki = 30 microM)			[22]
Affected Drug/Substrate	Prostaglandin F2alpha	Modulation Type	Inhibition
Cell System	The Proximal Tubule (S2) Cells-OAT1
Cefazolin	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation 1	Cefazolin inhibits the transportation of Prostaglandin F2alpha by SLC22A6 (Ki = 180 microM)			[22]
Affected Drug/Substrate	Prostaglandin F2alpha	Modulation Type	Inhibition
Cell System	The Proximal Tubule (S2) Cells-OAT1
Cefoperazone	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation 1	Cefoperazone inhibits the transportation of Prostaglandin F2alpha by SLC22A6 (Ki = 210 microM)			[22]
Affected Drug/Substrate	Prostaglandin F2alpha	Modulation Type	Inhibition
Cell System	The Proximal Tubule (S2) Cells-OAT1
Cefotaxime	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation 1	Cefotaxime inhibits the transportation of Prostaglandin F2alpha by SLC22A6 (Ki = 3130 microM)			[22]
Affected Drug/Substrate	Prostaglandin F2alpha	Modulation Type	Inhibition
Cell System	The Proximal Tubule (S2) Cells-OAT1
Ceftriaxone	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation 1	Ceftriaxone inhibits the transportation of Prostaglandin F2alpha by SLC22A6 (Ki = 230 microM)			[22]
Affected Drug/Substrate	Prostaglandin F2alpha	Modulation Type	Inhibition
Cell System	The Proximal Tubule (S2) Cells-OAT1
Cephalothin	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation 1	Cephalothin inhibits the transportation of Prostaglandin F2alpha by SLC22A6 (Ki = 220 microM)			[22]
Affected Drug/Substrate	Prostaglandin F2alpha	Modulation Type	Inhibition
Cell System	The Proximal Tubule (S2) Cells-OAT1
Candesartan	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation 1	Candesartan inhibits the transportation of Uric acid by SLC22A6 (IC50 = 17 microM)			[30]
Affected Drug/Substrate	Uric acid	Modulation Type	Inhibition
Cell System	Human embryonic kidney 293 cells (HEK293)-OAT1
Losartan	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation 1	Losartan inhibits the transportation of Uric acid by SLC22A6 (IC50 = 12 microM)			[30]
Affected Drug/Substrate	Uric acid	Modulation Type	Inhibition
Cell System	Human embryonic kidney 293 cells (HEK293)-OAT1
Olmesartan medoxomil	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation 1	Olmesartan medoxomil inhibits the transportation of Uric acid by SLC22A6 (IC50 = 0.28 microM)			[30]
Affected Drug/Substrate	Uric acid	Modulation Type	Inhibition
Cell System	Human embryonic kidney 293 cells (HEK293)-OAT1
Telmisartan	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation 1	Telmisartan inhibits the transportation of Uric acid by SLC22A6 (IC50 = 0.46 microM)			[30]
Affected Drug/Substrate	Uric acid	Modulation Type	Inhibition
Cell System	Human embryonic kidney 293 cells (HEK293)-OAT1
Valsartan	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation 1	Valsartan inhibits the transportation of Uric acid by SLC22A6 (IC50 = 16 microM)			[30]
Affected Drug/Substrate	Uric acid	Modulation Type	Inhibition
Cell System	Human embryonic kidney 293 cells (HEK293)-OAT1
Doxycycline	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation 1	Doxycycline inhibits the transportation of Aminohippuric acid by SLC22A6			[33]
Affected Drug/Substrate	Aminohippuric acid	Modulation Type	Inhibition
Cell System	The Proximal Tubule (S2) Cells-OAT1
Minocycline	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation 1	Minocycline inhibits the transportation of Aminohippuric acid by SLC22A6			[33]
Affected Drug/Substrate	Aminohippuric acid	Modulation Type	Inhibition
Cell System	The Proximal Tubule (S2) Cells-OAT1
Oxytetracycline	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation 1	Oxytetracycline inhibits the transportation of Aminohippuric acid by SLC22A6			[33]
Affected Drug/Substrate	Aminohippuric acid	Modulation Type	Inhibition
Cell System	The Proximal Tubule (S2) Cells-OAT1
Fluorescein	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation 1	Fluorescein inhibits the transportation of Aminohippuric acid by SLC22A6			[18]
Affected Drug/Substrate	Aminohippuric acid	Modulation Type	Inhibition
Cell System	Human cervical cancer cell line (Hela)-OAT1
Caspofungin	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation 1	Caspofungin inhibits the transportation of Aminohippuric acid by SLC22A6			[34]
Affected Drug/Substrate	Aminohippuric acid	Modulation Type	Inhibition
Cell System	Human cervical cancer cell line (Hela)-OAT1
Linagliptin	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation 1	Linagliptin inhibits the transportation of Aminohippuric acid by SLC22A6			[9]
Affected Drug/Substrate	Aminohippuric acid	Modulation Type	Inhibition
Cell System	Human embryonic kidney 293 cells (HEK293)-OAT1
Imipenem	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation 1	Imipenem significantly inhibits the uptake of cilastatin by SLC22A6			[35]
Affected Drug/Substrate	Cilastatin	Modulation Type	Inhibition
Cell System	Human embryonic kidney 293 cells (HEK293)-OAT1
Phenylbutazone	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation 1	Phenylbutazone inhibits the transportation of Methotrexate by SLC22A6			[37]
Affected Drug/Substrate	Methotrexate	Modulation Type	Inhibition
Cell System	The Proximal Tubule (S2) Cells-OAT1
Cinoxacin	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation 1	Cinoxacin inhibits the transportation of P-aminohippuric acid by SLC22A6			[40]
Affected Drug/Substrate	P-aminohippuric acid	Modulation Type	Inhibition
Quercetin	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation 1	Quercetin inhibits the transportation of Para-aminohippuric acid by SLC22A6			[31]
Affected Drug/Substrate	Para-aminohippuric acid	Modulation Type	Inhibition
Bendroflumethiazide	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation 1	Bendroflumethiazide inhibits the transportation of Polycyclic aromatic hydrocarbons by SLC22A6			[41]
Affected Drug/Substrate	Polycyclic aromatic hydrocarbons	Modulation Type	Inhibition
Piperacillin	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation 1	Piperacillin inhibits the transporation of tazobactam by SLC22A6 (IC50 = 54.32 microM; Ki = 37 microM)			[43]
Affected Drug/Substrate	Tazobactam	Modulation Type	Inhibition
Cell System	Human embryonic kidney 293 cells (HEK293)
Acetaminophen	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation 1	Acetaminophen inhibits the expression of SLC22A6			[44]
Cefaclor	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation 1	Cefaclor inhibits the activity of SLC22A6			[46]
Amoxicillin	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation 1	Amoxicillin inhibits the activity of SLC22A6			[47]
Cimetidine	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation 1	Cimetidine inhibits the activity of SLC22A6			[11]
Lumiracoxib	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation 1	Lumiracoxib inhibits the activity of SLC22A6			[48]
Vancomycin	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation 1	Vancomycin inhibits the activity of SLC22A6			[49]
Selexipag	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation 1	Selexipag inhibits the activity of SLC22A6			[50]
Eetuximab	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation 1	Eetuximab inhibits the activity of SLC22A6			[51]
Drug Marketed but not Approved by US FDA
Linoleic Acid	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation 1	Linoleic Acid inhibits the activity of SLC22A6			[45]
Drug in Phase 3 Trial
Benzylpenicillin	2 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation 1	Benzylpenicillin inhibits the transportation of Aminohippuric acid by SLC22A6			[24]
Affected Drug/Substrate	Aminohippuric acid	Modulation Type	Inhibition
Cell System	Oocytes-OAT1
DT Modulation 2	Benzylpenicillin inhibits the transportation of Ochratoxin A by SLC22A6			[8]
Affected Drug/Substrate	Ochratoxin A	Modulation Type	Inhibition
Cell System	The Proximal Tubule (S2) Cells-OAT1
Pratosartan	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation 1	Pratosartan inhibits the transportation of Uric acid by SLC22A6 (IC50 = 1.5 microM)			[30]
Affected Drug/Substrate	Uric acid	Modulation Type	Inhibition
Cell System	Human embryonic kidney 293 cells (HEK293)-OAT1
Drug in Phase 1/2 Trial
PRI-724	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation 1	PRI-724 inhibits the activity of SLC22A6			[52]
Cell System	Human embryonic kidney 293 cells (HEK293)-
Drug in Phase 1 Trial
FT-0755769	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation 1	FT-0755769 increases the activity of SLC22A6			[53]
Drug in Preclinical Test
Emodin	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation 1	Emodin inhibits the activity of SLC22A6			[45]
Discontinued Drug
Cyclic cidofovir	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation 1	Cyclic cidofovir inhibits the transportation of 6-Carboxyfluorescein by SLC22A6 (IC50 = 1100 microM)			[1]
Affected Drug/Substrate	6-Carboxyfluorescein	Modulation Type	Inhibition
Cell System	Chinese hamster ovary (CHO) cells-OAT1
Investigative Drug
Aminohippuric acid	5 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation 1	Aminohippuric acid inhibits the transportation of 6-Carboxyfluorescein by SLC22A6 (IC50 = 8.8 microM)			[1]
Affected Drug/Substrate	6-Carboxyfluorescein	Modulation Type	Inhibition
Cell System	Chinese hamster ovary (CHO) cells-OAT1
DT Modulation 2	Aminohippuric acid inhibits the transportation of Bestatin by SLC22A6 (IC50 = 106 microM; Ki = 92 microM)			[12]
Affected Drug/Substrate	Bestatin	Modulation Type	Inhibition
Cell System	Human embryonic kidney 293 cells (HEK293)-OAT1
DT Modulation 3	Aminohippuric acid inhibits the transportation of Ochratoxin A by SLC22A6 (Ki = 6.02 microM)			[8]
Affected Drug/Substrate	Ochratoxin A	Modulation Type	Inhibition
Cell System	The Proximal Tubule (S2) Cells-OAT1
DT Modulation 4	Aminohippuric acid inhibits the transportation of Uric acid by SLC22A6 (IC50 = 127 microM)			[13]
Affected Drug/Substrate	Uric acid	Modulation Type	Inhibition
Cell System	The Proximal Tubule (S2) Cells-OAT1
DT Modulation 5	Aminohippuric acid inhibits the activity of SLC22A6			[14]
Cell System	The Proximal Tubule (S2) Cells-OAT1
Glutarate	2 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation 1	Glutarate inhibits the transportation of 6-Carboxyfluorescein by SLC22A6 (IC50 = 4.9 microM)			[1]
Affected Drug/Substrate	6-Carboxyfluorescein	Modulation Type	Inhibition
Cell System	Chinese hamster ovary (CHO) cells-OAT1
DT Modulation 2	Glutarate inhibits the transportation of Aminohippuric acid by SLC22A6 (IC50 = 3.3 microM)			[21]
Affected Drug/Substrate	Aminohippuric acid	Modulation Type	Inhibition
Cell System	Human embryonic kidney 293 cells (HEK293)-OAT1
Adipate	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation 1	Adipate inhibits the transportation of Aminohippuric acid by SLC22A6 (IC50 = 6.2 microM)			[21]
Affected Drug/Substrate	Aminohippuric acid	Modulation Type	Inhibition
Cell System	Human embryonic kidney 293 cells (HEK293)-OAT1
Alpha-ketoglutaric acid	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation 1	Alpha-ketoglutaric acid inhibits the transportation of Aminohippuric acid by SLC22A6 (IC50 = 4.7 microM)			[21]
Affected Drug/Substrate	Aminohippuric acid	Modulation Type	Inhibition
Cell System	Human embryonic kidney 293 cells (HEK293)-OAT1
Fumarate	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation 1	Fumarate inhibits the transportation of Aminohippuric acid by SLC22A6 (IC50 = 1733 microM)			[21]
Affected Drug/Substrate	Aminohippuric acid	Modulation Type	Inhibition
Cell System	Human embryonic kidney 293 cells (HEK293)-OAT1
Morin	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation 1	Morin inhibits the transportation of Para-aminohippuric acid by SLC22A6 (IC50 = 0.3 microM)			[31]
Affected Drug/Substrate	Para-aminohippuric acid	Modulation Type	Inhibition
21H7	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation 1	21H7 inhibits the activity of SLC22A6			[52]
Cell System	Human embryonic kidney 293 cells (HEK293)-
FH535	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation 1	FH535 inhibits the activity of SLC22A6			[52]
Cell System	Human embryonic kidney 293 cells (HEK293)-
p-aminohippurate	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation 1	p-aminohippurate inhibits the uptake of imipenem by SLC22A6			[35]
Affected Drug/Substrate	Imipenem	Modulation Type	Inhibition
Cell System	Human embryonic kidney 293 cells (HEK293)-OAT1
JBP485	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation 1	JBP485 inhibits the uptake of imipenem by SLC22A6			[58]
Affected Drug/Substrate	Imipenem	Modulation Type	Inhibition
Cell System	Human embryonic kidney 293 cells (HEK293)-OAT1
Drug Withdrawn
Cephaloridine	2 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation 1	Cephaloridine inhibits the transportation of 6-Carboxyfluorescein by SLC22A6 (IC50 = 1250 microM)			[1]
Affected Drug/Substrate	6-Carboxyfluorescein	Modulation Type	Inhibition
Cell System	Chinese hamster ovary (CHO) cells-OAT1
DT Modulation 2	Cephaloridine inhibits the transportation of Prostaglandin F2alpha by SLC22A6 (Ki = 740 microM)			[22]
Affected Drug/Substrate	Prostaglandin F2alpha	Modulation Type	Inhibition
Cell System	The Proximal Tubule (S2) Cells-OAT1
Phenacetin	2 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation 1	Phenacetin inhibits the transportation of Adefovir by SLC22A6 (IC50 = 200 microM)			[2]
Affected Drug/Substrate	Adefovir	Modulation Type	Inhibition
Cell System	Chinese hamster ovary (CHO) cells-OAT1
DT Modulation 2	Phenacetin inhibits the transportation of Aminohippuric acid by SLC22A6 (IC50 = 275 microM)			[15]
Affected Drug/Substrate	Aminohippuric acid	Modulation Type	Inhibition
Cell System	The Proximal Tubule (S2) Cells-OAT1
Natural Product
Citreoverdine	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation 1	Citreoverdine inhibits the transportation of Organic anion by SLC22A6 (IC50 = 16.9 microM)			[27]
Affected Drug/Substrate	Organic anion	Modulation Type	Inhibition
Cell System	The Proximal Tubule (S2) Cells-OAT1
Cyclopiazonic acid	2 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation 1	Cyclopiazonic acid inhibits the transportation of Organic anion by SLC22A6 (IC50 = 6.59 microM)			[27]
Affected Drug/Substrate	Organic anion	Modulation Type	Inhibition
Cell System	The Proximal Tubule (S2) Cells-OAT1
Fumonisin B1	2 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation 1	Fumonisin B1 inhibits the transportation of Organic anion by SLC22A6 (IC50 = 768 microM)			[27]
Affected Drug/Substrate	Organic anion	Modulation Type	Inhibition
Cell System	The Proximal Tubule (S2) Cells-OAT1
Patulin	2 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation 1	Patulin inhibits the transportation of Organic anion by SLC22A6 (IC50 = 44.8 microM)			[27]
Affected Drug/Substrate	Organic anion	Modulation Type	Inhibition
Cell System	The Proximal Tubule (S2) Cells-OAT1
Gallic Acid	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation 1	Gallic acid inhibits the transportation of P-aminohippuric acid by SLC22A6 (IC50 = 1.2 microM)			[28]
Affected Drug/Substrate	P-aminohippuric acid	Modulation Type	Inhibition
Cell System	Chinese hamster ovary (CHO) cells-OAT1
Rosmarinic acid	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation 1	Rosmarinic acid inhibits the transportation of P-aminohippuric acid by SLC22A6 (Ki = 0.35 microM)			[28]
Affected Drug/Substrate	P-aminohippuric acid	Modulation Type	Inhibition
Cell System	Chinese hamster ovary (CHO) cells-OAT1
Rhein	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation 1	Rhubarb inhibits the transportation of P-aminohippuric acid by SLC22A6 in a competitive manner (IC50 = 0.072 microM)			[29]
Affected Drug/Substrate	P-aminohippuric acid	Modulation Type	Inhibition
Cell System	Chinese hamster ovary (CHO) cells-OAT1
Luteolin	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation 1	Luteolin inhibits the transportation of Para-aminohippuric acid by SLC22A6 (IC50 = 0.47 microM)			[31]
Affected Drug/Substrate	Para-aminohippuric acid	Modulation Type	Inhibition
Quercetin-3-O-sulfate	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation 1	Quercetin-3-O-sulfate inhibits the transportation of Para-aminohippuric acid by SLC22A6 (IC50 = 1.22 microM)			[32]
Affected Drug/Substrate	Para-aminohippuric acid	Modulation Type	Inhibition
Ellagic acid	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation 1	Ellagic acid inhibits the transportation of Para-aminohippuric acid by SLC22A6			[38]
Affected Drug/Substrate	Para-aminohippuric acid	Modulation Type	Inhibition
Cell System	Xenopus laevis oocytes-OAT1
Silybin	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation 1	Silybin inhibits the transportation of Para-aminohippuric acid by SLC22A6 in a competitive manner			[39]
Affected Drug/Substrate	Para-aminohippuric acid	Modulation Type	Inhibition
Cell System	Madin darby canine kidney strain cell line (MDCK)-OAT1
Fisetin	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation 1	Fisetin inhibits the transportation of Para-aminohippuric acid by SLC22A6 through competitive inhibition			[31]
Affected Drug/Substrate	Para-aminohippuric acid	Modulation Type	Inhibition
Genistein-4-O-sulfate	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation 1	Genistein-4-O-sulfate inhibits the transportation of Para-aminohippuric acid by SLC22A6			[32]
Affected Drug/Substrate	Para-aminohippuric acid	Modulation Type	Inhibition
Cigarette smoke condensate (0.08mg/ml)	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation 1	Cigarette smoke condensate (0.08mg/ml) inhibits the activity of SLC22A6			[42]
Cell System	Human embryonic kidney 293 cells (HEK293)-OAT1
Cigarette smoke condensate (0.32mg/ml)	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation 1	Cigarette smoke condensate (0.32mg/ml) inhibits the activity of SLC22A6			[42]
Cell System	Human embryonic kidney 293 cells (HEK293)-OAT1
Tobacco Smoke Pollution	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation 1	Tobacco Smoke Pollution inhibits the activity of SLC22A6			[42]
Chrysophanic acid	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation 1	Chrysophanic acid inhibits the activity of SLC22A6			[45]
Baicalein	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation 1	Baicalein inhibits the activity of SLC22A6			[56]
Wogonin	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation 1	Wogonin inhibits the activity of SLC22A6			[56]
Oroxylin A	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation 1	Oroxylin A inhibits the activity of SLC22A6 (IC50 = 0.961 microM)			[57]
Cell System	Human embryonic kidney 293 cells (HEK293)-SLC22A6
Dietary Constituent
Danshen	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation 1	Danshen inhibits the transportation of P-aminohippuric acid by SLC22A6 (Ki = 40.4 microM)			[28]
Affected Drug/Substrate	P-aminohippuric acid	Modulation Type	Inhibition
Cell System	Chinese hamster ovary (CHO) cells-OAT1
Mycotoxins
DT Modulation 1	Cyclopiazonic acid inhibits the transportation of Organic anion by SLC22A6 (IC50 = 6.59 microM)			[27]
Affected Drug/Substrate	Organic anion	Modulation Type	Inhibition
Cell System	The Proximal Tubule (S2) Cells-OAT1
DT Modulation 1	Fumonisin B1 inhibits the transportation of Organic anion by SLC22A6 (IC50 = 768 microM)			[27]
Affected Drug/Substrate	Organic anion	Modulation Type	Inhibition
Cell System	The Proximal Tubule (S2) Cells-OAT1
DT Modulation 1	Patulin inhibits the transportation of Organic anion by SLC22A6 (IC50 = 44.8 microM)			[27]
Affected Drug/Substrate	Organic anion	Modulation Type	Inhibition
Cell System	The Proximal Tubule (S2) Cells-OAT1
Aflatoxin B1	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation 1	Aflatoxin B1 inhibits the transportation of Organic anion by SLC22A6 (IC50 = 12.3 microM)			[27]
Affected Drug/Substrate	Organic anion	Modulation Type	Inhibition
Cell System	The Proximal Tubule (S2) Cells-OAT1
Alpha-zearalenol	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation 1	Alpha-zearalenol inhibits the transportation of Organic anion by SLC22A6 (IC50 = 28.4 microM)			[27]
Affected Drug/Substrate	Organic anion	Modulation Type	Inhibition
Cell System	The Proximal Tubule (S2) Cells-OAT1
Citrioveridine	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation 1	Citrioveridine inhibits the transportation of Organic anion by SLC22A6 (IC50 = 16.9 microM)			[27]
Affected Drug/Substrate	Organic anion	Modulation Type	Inhibition
Cell System	The Proximal Tubule (S2) Cells-OAT1
Gliotoxin	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation 1	Gliotoxin inhibits the transportation of Organic anion by SLC22A6 (IC50 = 117 microM)			[27]
Affected Drug/Substrate	Organic anion	Modulation Type	Inhibition
Cell System	The Proximal Tubule (S2) Cells-OAT1
Zearalenone	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation 1	Zearalenone inhibits the transportation of Organic anion by SLC22A6 (IC50 = 147 microM)			[27]
Affected Drug/Substrate	Organic anion	Modulation Type	Inhibition
Cell System	The Proximal Tubule (S2) Cells-OAT1
Acute Toxic Substance
2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation 1	2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine inhibits the activity of SLC22A6			[42]
Carcinogen
Benzo(a)pyrene	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation 1	Benzo(a)pyrene inhibits the activity of SLC22A6			[55]
Pesticide/Insecticide
Clothianidin	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation 1	Clothianidin inhibits the activity of SLC22A6			[54]

References
1	Fluorescence-based assay for the interaction of small molecules with the human renal organic anion transporter 1. Anal Biochem. 2000 Jul 15;283(1):49-55.
2	Nonsteroidal anti-inflammatory drugs efficiently reduce the transport and cytotoxicity of adefovir mediated by the human renal organic anion transporter 1. J Pharmacol Exp Ther. 2000 Oct;295(1):10-5.
3	Cytotoxicity of antiviral nucleotides adefovir and cidofovir is induced by the expression of human renal organic anion transporter 1. J Am Soc Nephrol. 2000 Mar;11(3):383-93.
4	Characterization of organic anion transport inhibitors using cells stably expressing human organic anion transporters. Eur J Pharmacol. 2001 May 11;419(2-3):113-20.
5	In vitro risk assessment of AZD9056 perpetrating a transporter-mediated drug-drug interaction with methotrexate. Eur J Pharm Sci. 2011 May 18;43(1-2):41-9.
6	Transport of the dipeptidyl peptidase-4 inhibitor sitagliptin by human organic anion transporter 3, organic anion transporting polypeptide 4C1, and multidrug resistance P-glycoprotein. J Pharmacol Exp Ther. 2007 May;321(2):673-83.
7	In vitro and in vivo assessment of renal drug transporters in the disposition of mesna and dimesna. J Clin Pharmacol. 2012 Apr;52(4):530-42.
8	Characterization of ochratoxin A transport by human organic anion transporters. Life Sci. 2001 Sep 21;69(18):2123-35.
9	Evaluation and prediction of potential drug-drug interactions of linagliptin using in vitro cell culture methods. Drug Metab Dispos. 2013 Jan;41(1):149-58.
10	Human organic anion transporters and human organic cation transporters mediate renal antiviral transport. J Pharmacol Exp Ther. 2002 Mar;300(3):918-24.
11	Characterization of the renal tubular transport of zonampanel, a novel alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptor antagonist, by human organic anion transporters. Drug Metab Dispos. 2004 Oct;32(10):1096-102.
12	Organic anion transporters involved in the excretion of bestatin in the kidney. Peptides. 2012 Feb;33(2):265-71.
13	Urate transport via human PAH transporter hOAT1 and its gene structure. Kidney Int. 2003 Jan;63(1):143-55.
14	Elucidation of common pharmacophores from analysis of targeted metabolites transported by the multispecific drug transporter-Organic anion transporter1 (Oat1). Bioorg Med Chem. 2011 Jun 1;19(11):3320-40.
15	Interactions of human organic anion transporters and human organic cation transporters with nonsteroidal anti-inflammatory drugs. J Pharmacol Exp Ther. 2002 Nov;303(2):534-9.
16	The contribution of organic anion transporters OAT1 and OAT3 to the renal uptake of rosuvastatin. J Pharmacol Exp Ther. 2007 Sep;322(3):1221-7.
17	Evidence for a role of human organic anion transporters in the muscular side effects of HMG-CoA reductase inhibitors. Eur J Pharmacol. 2004 Jan 12;483(2-3):133-8.
18	Cloning of the human kidney PAH transporter: narrow substrate specificity and regulation by protein kinase C. Am J Physiol. 1999 Feb;276(2):F295-303.
19	Interactions of human organic anion transporters with diuretics. J Pharmacol Exp Ther. 2004 Mar;308(3):1021-9.
20	Inhibitory effects of ketoconazole and rifampin on OAT1 and OATP1B1 transport activities: considerations on drug-drug interactions. Biopharm Drug Dispos. 2011 Apr;32(3):175-84.
21	Differential interaction of dicarboxylates with human sodium-dicarboxylate cotransporter 3 and organic anion transporters 1 and 3. Am J Physiol Renal Physiol. 2011 Nov;301(5):F1026-34.
22	Interaction of human and rat organic anion transporter 2 with various cephalosporin antibiotics. Eur J Pharmacol. 2003 Mar 28;465(1-2):1-7.
23	Interaction and transport of thiazide diuretics, loop diuretics, and acetazolamide via rat renal organic anion transporter rOAT1. J Pharmacol Exp Ther. 2000 Oct;295(1):261-5.
24	Molecular cloning and functional expression of a multispecific organic anion transporter from human kidney. Am J Physiol. 1999 Jan;276(1):F122-8.
25	Blockade of Organic Anion Transport in Humans After Treatment With the Drug Probenecid Leads to Major Metabolic Alterations in Plasma and Urine. Clin Pharmacol Ther. 2022 Sep;112(3):653-664.
26	Novobiocin is a potent inhibitor for human organic anion transporters. Drug Metab Dispos. 2009 Jun;37(6):1203-10.
27	Interactions of organic anion transporters and organic cation transporters with mycotoxins. J Pharmacol Sci. 2008 Mar;106(3):435-43.
28	Organic solute carrier 22 (SLC22) family: Potential for interactions with food, herbal/dietary supplements, endogenous compounds, and drugs. J Food Drug Anal. 2018 Apr;26(2S):S45-S60.
29	The anthraquinone drug rhein potently interferes with organic anion transporter-mediated renal elimination. Biochem Pharmacol. 2013 Oct 1;86(7):991-6.
30	Involvement of uric acid transporters in alteration of serum uric acid level by angiotensin II receptor blockers. Pharm Res. 2008 Mar;25(3):639-46.
31	Flavonoids are inhibitors of human organic anion transporter 1 (OAT1)-mediated transport. Drug Metab Dispos. 2014 Sep;42(9):1357-66.
32	Flavonoid conjugates interact with organic anion transporters (OATs) and attenuate cytotoxicity of adefovir mediated by organic anion transporter 1 (OAT1/SLC22A6). Biochem Pharmacol. 2011 Apr 1;81(7):942-9.
33	Human organic anion transporters mediate the transport of tetracycline. Jpn J Pharmacol. 2002 Jan;88(1):69-76.
34	Hepatic uptake of the novel antifungal agent caspofungin. Drug Metab Dispos. 2005 May;33(5):676-82.
35	Organic anion transporters also mediate the drug-drug interaction between imipenem and cilastatin. Asian J Pharm Sci. 2020 Mar;15(2):252-263.
36	Overcoming ABCB1-mediated multidrug resistance by transcription factor BHLHE40. Neoplasia. 2023 May;39:100891.
37	Characterization of methotrexate transport and its drug interactions with human organic anion transporters. J Pharmacol Exp Ther. 2002 Aug;302(2):666-71.
38	The dietary polyphenol ellagic acid is a potent inhibitor of hOAT1. Drug Metab Dispos. 2005 Aug;33(8):1097-100.
39	Interaction characteristics of flavonoids with human organic anion transporter 1 (hOAT1) and 3 (hOAT3). Pharmacol Res. 2007 Dec;56(6):468-73.
40	The interaction and transport of beta-lactam antibiotics with the cloned rat renal organic anion transporter 1. J Pharmacol Exp Ther. 1999 Aug;290(2):672-7.
41	Overlapping in vitro and in vivo specificities of the organic anion transporters OAT1 and OAT3 for loop and thiazide diuretics. Am J Physiol Renal Physiol. 2008 Apr;294(4):F867-73.
42	Inhibition of organic anion transporter (OAT) activity by cigarette smoke condensate. Toxicol In Vitro. 2017 Oct;44:27-35.
43	OAT1 and OAT3 also mediate the drug-drug interaction between piperacillin and tazobactam. Int J Pharm. 2018 Feb 15;537(1-2):172-182.
44	Predictive toxicology using systemic biology and liver microfluidic "on chip" approaches: application to acetaminophen injury. Toxicol Appl Pharmacol. 2012 Mar 15;259(3):270-80.
45	From the Cover: Identification of Natural Products as Inhibitors of Human Organic Anion Transporters (OAT1 and OAT3) and Their Protective Effect on Mercury-Induced Toxicity. Toxicol Sci. 2018 Feb 1;161(2):321-334.
46	Interactions of amoxicillin and cefaclor with human renal organic anion and peptide transporters. Drug Metab Dispos. 2006 Apr;34(4):547-55.
47	The anti-influenza drug oseltamivir exhibits low potential to induce pharmacokinetic drug interactions via renal secretion-correlation of in vivo and in vitro studies. Drug Metab Dispos. 2002 Jan;30(1):13-9.
48	Inhibitory effect of selective cyclooxygenase-2 inhibitor lumiracoxib on human organic anion transporters hOAT1 and hOAT3. Drug Metab Pharmacokinet. 2010;25(5):450-5.
49	JBP485 attenuates vancomycin-induced nephrotoxicity by regulating the expressions of organic anion transporter (Oat) 1, Oat3, organic cation transporter 2 (Oct2), multidrug resistance-associated protein 2 (Mrp2) and P-glycoprotein (P-gp) in rats. Toxicol Lett. 2018 Oct 1;295:195-204.
50	The metabolism and drug-drug interaction potential of the selective prostacyclin receptor agonist selexipag. Xenobiotica. 2018 Jul;48(7):704-719.
51	Cetuximab Prevents Methotrexate-Induced Cytotoxicity in Vitro through Epidermal Growth Factor Dependent Regulation of Renal Drug Transporters. Mol Pharm. 2017 Jun 5;14(6):2147-2157.
52	Impaired Transport Activity of Human Organic Anion Transporters (OATs) and Organic Anion Transporting Polypeptides (OATPs) by Wnt Inhibitors. J Pharm Sci. 2021 Feb;110(2):914-924.
53	The chloride dependence of the human organic anion transporter 1 (hOAT1) is blunted by mutation of a single amino acid. J Biol Chem. 2007 May 4;282(18):13402-9.
54	Neonicotinoid pesticides poorly interact with human drug transporters. J Biochem Mol Toxicol. 2019 Oct;33(10):e22379.
55	Involvement of aryl hydrocarbon receptor in the cytotoxicity of corannulene and its derivatives. Toxicol Lett. 2020 Mar 15;321:114-121.
56	Potent Inhibitors of Organic Anion Transporters 1 and 3 From Natural Compounds and Their Protective Effect on Aristolochic Acid Nephropathy. Toxicol Sci. 2020 Jun 1;175(2):279-291.
57	Interactions between Oroxylin A with the solute carrier transporters and ATP-binding cassette transporters: Drug transporters profile for this flavonoid. Chem Biol Interact. 2020 Jun 1;324:109097.
58	JBP485, A Dual Inhibitor of Organic Anion Transporters (OATs) and Renal Dehydropeptidase-I (DHP-I), Protects Against Imipenem-Induced Nephrotoxicity. Front Pharmacol. 2022 Jun 8;13:938813.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.

Detail Information of Exogenous Modulation

Visitor Map

Correspondence